Epigenomics and Quest sign nonexclusive licensing agreement for mGSTP1 DNA biomarker Feb. 27, 2009 No Comments
Neogenix to initiate clinical trial of monoclonal antibodies for colorectal and pancreatic cancer Dec. 15, 2008 No Comments
Epigenomics presents update on PRESEPT clinical study of Septin 9 biomarker in colorectal cancer Oct. 28, 2008 No Comments
FDA grants regulatory clearance to Response Biomedical to market Ramp NT-proBNP test for HF July 25, 2008 No Comments
BioMarker Pharmaceuticals launches Gene Essence genome analysis test in the U.S. April 4, 2008 No Comments
RSS